Enhancing Methylphenidate's Neurocognitive Effects in Pediatric ADHD with Adaptive Digital Therapy: A Randomized
Xiaolu Chen1, Sihan Wang2, Xiaowen Yang1
1Department of Pediatrics, West China Second University Hospital; Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of the Ministry of Education, Sichuan University, Chengdu, 610041, People's Republic of China.
Combining digital therapeutics with methylphenidate (MPH) significantly improved objective neurocognitive outcomes in children with ADHD, enhancing attention and executive functions. This digital therapy approach shows promise for pediatric ADHD treatment.
Area of Science:
- Neuroscience
- Pediatric Psychology
- Digital Health
Background:
- Digital therapeutics are emerging as adjunctive treatments for Attention-Deficit/Hyperactivity Disorder (ADHD).
- Rigorous trial evidence for digital therapeutics in ADHD is still limited.
- This study investigated the added neurocognitive benefits of a digital therapy (Focus Pro) with methylphenidate (MPH).
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drug Therapy
Antianxiety Medications
